入排依据:The record describes a Phase III randomized trial with drug intervention in human oncology, but the provided metadata (title, abstract, MeSH terms, keywords) does not explicitly mention or signal a time-to-event efficacy endpoint (e.g., OS, PFS, DFS, Kaplan-Meier, HR). Therefore, it cannot be confirmed as eligible for the cohort.
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板